CORESTEMCHEMON Inc. (KOSDAQ:166480)

South Korea · Delayed Price · Currency is KRW

1,587.00

-14.00 (-0.87%)

At close: Nov 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Non-Clinical Trial Agency Division	19.97B	27.64B	32.02B	40.87B	29.14B
Cell Therapy Pharmaceutical Sector	187.62M	1.56B	2.12B	5.49B	1.57B
Unallocated Adjustments	-	-440.00M	-480.00M	-480.00M	-471.40M
Total	20.16B	28.76B	33.66B	45.88B	30.24B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	20.16B	29.18B	33.93B	45.88B	30.24B
Consolidation Adjustment	-	-440.00M	-480.00M	-	-
Other	-	26.57M	-	-	-
Asia	-	-	210.94M	-	-
Total	20.16B	28.76B	33.66B	45.88B	30.24B